Table 5.
DFS | ||
---|---|---|
Variables | HR(95%CI) | P-value |
Univariate analysis | ||
Age | ||
≧50 | 1.0 | |
< 50 | 0.82(0.28–2.38) | 0.717 |
Menopause status | ||
Post | 1.0 | |
Pre | 0.81(0.27–2.38) | 0.707 |
Tumor size | ||
< 2 | 1.0 | |
2 ≤ T < 5 | 1.84(0.51–6.60) | |
5≥ | 19.53(4.11–92.82) | <0.001 |
Lymph node status | ||
Negative | 1.0 | |
Positive | 3.78(1.18–12.07) | 0.015 |
Histological grade | ||
1 | 1.0 | |
2 | 2.25(0.64–7.89) | |
3 | 2.20(0.24–20.04) | 0.400 |
Multivariate analysis | ||
Tumor size | ||
< 2 | 1.0 | |
2 ≤ T < 5 | 1.49(0.39–5.61) | |
5≥ | 10.18(1.79–57.75) | 0.024 |
Lymph node status | ||
Negative | 1.0 | |
Positive | 2.18(0.58–8.14) | 0.207 |
ILC invasive lobular carcinoma, DFS disease free survival, HR hazard ratio, 95 % CI 95 % confidence interval